Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.830
+0.070 (3.98%)
Mar 31, 2025, 2:33 PM EDT - Market open
Evaxion Biotech Employees
Evaxion Biotech had 49 employees as of December 31, 2023. The number of employees decreased by 14 or -22.22% compared to the previous year.
Employees
49
Change (1Y)
-14
Growth (1Y)
-22.22%
Revenue / Employee
$67,245
Profits / Employee
-$233,898
Market Cap
11.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | 35 | -1 | -2.78% |
| Dec 31, 2019 | 36 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVAX News
- 4 days ago - Evaxion to announce business update and full year 2024 financial results on April 1, 2025 - GlobeNewsWire
- 5 days ago - Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting - GlobeNewsWire
- 4 weeks ago - Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package - GlobeNewsWire
- 2 months ago - Evaxion announces closing of $10.8 million public offering - GlobeNewsWire
- 2 months ago - Evaxion announces pricing of $10.8 million public offering - GlobeNewsWire
- 2 months ago - Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement - GlobeNewsWire
- 2 months ago - Evaxion announces completion of ADS ratio change - GlobeNewsWire
- 2 months ago - Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change - GlobeNewsWire